Literature DB >> 18458649

Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial.

Maria E Santolaya1, Ana M Alvarez, Carmen L Aviles, Ana Becker, Alejandra King, Claudio Mosso, Miguel O'Ryan, Ernesto Paya, Carmen Salgado, Pamela Silva, Santiago Topelberg, Juan Tordecilla, Monica Varas, Milena Villarroel, Tamara Viviani, Marcela Zubieta.   

Abstract

BACKGROUND: Severe sepsis is not clinically apparent during the first 24 hours of hospitalization in most children with cancer and febrile neutropenia (FN), delaying targeted interventions that could impact mortality. The aim of this study was to prospectively evaluate biomarkers obtained within 24 hours of hospitalization as predictors of severe sepsis before it becomes clinically evident.
METHODS: Children with cancer, admitted with FN at high risk for an invasive bacterial infection in 6 public hospitals in Santiago, Chile, were monitored throughout their clinical course for occurrence of severe sepsis. Clinical, demographic and 6 biomarkers [eg, blood urea nitrogen, serum glucose, lactic dehydrogenase, serum C-reactive protein (CRP), interleukin (IL)-8, and procalcitonin] were obtained at the time of admission and after 24 hours. Biomarkers independently associated with severe sepsis diagnosed after the first 24 hours of hospitalization were identified by logistic regression analysis.
RESULTS: A total of 601 high risk FN episodes were enrolled between June 2004 and October 2006; 151 (25%) developed severe sepsis of which 116 (77%) were not clinically apparent during the first 24 hours of hospitalization. Risk factors for severe sepsis were age > or =12 years [odds ratio (OR): 3.85; 95% confidence interval (CI): 2.41-6.15], admission CRP > or =90 mg/L (OR: 2.03; 95% CI: 1.32-3.14), admission IL-8 > or =200 pg/mL (OR: 2.39; 95% CI: 1.51-3.78), 24-hour CRP > or =100 mg/L (OR: 3.06; 95% CI: 1.94-4.85), and 24-hour IL-8 > or =300 pg/mL (OR: 3.13; 95% CI 1.92-5.08).
CONCLUSIONS: Age > or =12 years and admission or 24-hour values of CRP > or =90/100 mg/L and IL-8 > or =200/300 pg/mL are predictors of sepsis not clinically apparent during the first 24 hours of hospitalization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458649     DOI: 10.1097/INF.0b013e3181673c3c

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  14 in total

1.  Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis.

Authors:  Bobby Tan; Judith Ju-Ming Wong; Rehena Sultana; Janine Cynthia Jia Wen Koh; Mark Jit; Yee Hui Mok; Jan Hau Lee
Journal:  JAMA Pediatr       Date:  2019-04-01       Impact factor: 16.193

2.  Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.

Authors:  Lidija Kitanovski; Janez Jazbec; Sergej Hojker; Metka Derganc
Journal:  Support Care Cancer       Date:  2013-09-21       Impact factor: 3.603

Review 3.  Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis.

Authors:  Chun-Wei Wu; Jiunn-Yih Wu; Chun-Kuei Chen; Shiau-Ling Huang; Shou-Chien Hsu; Meng-Tse Gabriel Lee; Shy-Shin Chang; Chien-Chang Lee
Journal:  Support Care Cancer       Date:  2015-02-21       Impact factor: 3.603

4.  Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia.

Authors:  Shin Ahn; Yoon-Seon Lee; Yun-Hee Chun; In-Ho Kwon; Won Kim; Kyung Soo Lim; Tae Won Kim; Kyoo-Hyung Lee
Journal:  Support Care Cancer       Date:  2010-06-16       Impact factor: 3.603

5.  A Dynamic Approach for Early Risk Prediction of Gram-Negative Bloodstream Infection and Systemic Inflammatory Response Syndrome in Febrile Pediatric Hemato-Oncology Patients.

Authors:  José Antonio Villegas Rubio; Pilar Palomo Moraleda; Ana De Lucio Delgado; Gonzalo Solís Sánchez; Belén Prieto García; Corsino Rey Galán
Journal:  Children (Basel)       Date:  2022-06-03

6.  Examination of Setarud (IMOD™) in the management of patients with severe sepsis.

Authors:  A Mahmoodpoor; K Eslami; M Mojtahedzadeh; A Najafi; A Ahmadi; A Dehnadi-Moghadam; A Mohammadirad; M Baeeri; M Abdollahi
Journal:  Daru       Date:  2010       Impact factor: 3.117

7.  Exploring the association of hemoglobin level and adverse events in children with cancer presenting with fever in neutropenia.

Authors:  Roland A Ammann; Felix K Niggli; Kurt Leibundgut; Oliver Teuffel; Nicole Bodmer
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

8.  TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients.

Authors:  Wen-Chien Fan; Chih-Wei Liu; Shuo-Ming Ou; Chia-Chang Huang; Tzu-Hao Li; Kuei-Chuan Lee; Shiang-Fen Huang; Ying-Ying Yang; Yun-Cheng Hsieh; Shie-Liang Hsieh; Ming-Chih Hou; Han-Chieh Lin
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

9.  Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia.

Authors:  Victoria Hemming; Adam D Jakes; Geoff Shenton; Bob Phillips
Journal:  BMC Pediatr       Date:  2017-01-05       Impact factor: 2.125

10.  Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.

Authors:  Maryke J Nielsen; Sarah Claxton; Barry Pizer; Steven Lane; Richard P D Cooke; Stéphane Paulus; Enitan D Carrol
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.